maximus glp 1 reviews GLP-1 Microdosing: Why Less Is the Future of Weight Loss Maximus Tribe Review: Editorial Look

36 Dedicated Heart Failure Trials The STEP-HFpEF, STEP-HFpEF DM and SUMMIT trials represent key advances in the evaluation of GLP-1RAs in the treatment of HF

Disclosures: Lauren Rutt: Nothing to Disclose, Rebecca McCullough: Nothing to Disclose 1483 NALTREXONE USE IN PATIENTS WITH COMBINED METABOLIC AND ALCOHOL-ASSOCIATED LIVER DISEASE (METALD), PROPENSITY SCORE MATCHED STUDY Amir Hossein Gougol 1 Paul Kwo 2 C Pike 3 Saurabh Gombar 3 Gavin Hui 3 , 1 Stanford University, 2 Stanford University Medical Center, 3 Atropos Health Background: Naltrexone has demonstrated efficacy in management of alcohol use disorder

The illness, called cyclosporiasis, is less common than foodborne illnesses caused by other germs, including salmonella and E

doi: 10.1038/nrendo.2012.140